Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the ...

Amgen yesterday revealed that Tepezza (teprotumumab [genetical recombination]) has been approved for the treatment of active ...

In a news packed morning, Japanese drugmaker Astellas Pharma (TYO: 4503) today revealed two regulatory approvals.

There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.

Japan’s MHLF approves Padcev with Keytruda for first-line treatment of radically unresectable urothelial carcinoma: Tokyo Wednesday, September 25, 2024, 11:00 Hrs [IST] Astellas ...

Amgen announced that Tepezza (teprotumumab [Genetical Recombination]) was approved by Japan's Ministry of Health, Labour and Welfare to treat active thyroid eye disease (TED) or TED with a high ...

All he required was a bit of space ahead of himself outside the penalty area to unleash the rocket that he can generate from his feet. A genetical freak in the way his body has been built, with ...

Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the treatment of active or high ...

The CENTRE, Rolla's Health & Recreation Complex is pleased to announce today that it has achieved certification by the Medical Fitness Association, the country's leading organization dedicated solely ...

Global IT solutions provider General Datatech (GDT) announced that it has acquired MDS Global IT (MDS) to expand its international collaboration and contact center ...

ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of gene expression, announced today its participation in the 8th Annual ...

[Molecular marker mapping of the gene resistant to common bunt transferred from Aegilops cylindrica into bread wheat].